Clinical Data

PocketVest has been shown to reduce pocket hematomas in post-operative CIED patients compared to control.

EP Lab Digest (2020)

Prevention and Treatment Strategies for Pocket Hematomas During CIED Implantation: Pocket Management Systems and Other Adjuvant Interventions

Sri Harsha Kanuri, MD; Mehmet Ali Elbey, MD; Donita Atkins, RN; Courtney Jeffery, APRN; Domenico G. Della Rocca, MD; Naresh Kodwani, MD; Andrea Natale, MD; Rakesh Gopinathannair, MD; Srijoy Mahapatra, MD; Dhanunjaya Lakkireddy, MD


Conclusions: Pocket hematomas are the most common complication post-CIED implantation that can lead to complications such as device infections, pocket revision, prolonged hospital stays, and economic losses. A number of interventions have been tried previously without much success. A pocket compression device, such as the PocketVest CIED Pocket Management System, has shown promise in preventing pocket hematomas by providing adequate compression, cooling, and immobilization. The PocketVest has been clinically proven to reduce local complications, decrease morbidity, and enhance clinical outcomes in previously conducted research studies.

J Intrev Card Electrophyisical (2017)

Use of a pocket compression device for the prevention and treatment of pocket hematoma after pacemaker and defibrillator implantation (STOP-HEMOTOMA I)

Mohit K Turagam, Darbhamulla V. Nagarajan, Krzysztof Bartus, Akash Makkar, Vijay Swarup

Conclusion: The risk of moderate or large pocket hematoma is significantly reduced with the use of this vest in high-risk patients undergoing implantable devices on uninterrupted antiplatelet and anticoagulants.

Indian Pacing and Electrophysiology Journal 16 (2016)

Incidence, predictors and outcomes of hematoma after ICD implantation: An analysis of a nationwide database of 85,276.

Arun Raghav Mahankali Sridhar, Vivek Yarlagdda, Arun Kammanthareddy, Sravanthi Parasa, Ryan Maybrook, Buddhadeb Dawn, Yeruva Madhu Reddy, Dhanunjaya Lakkireddy


Conclusions: Pocket hematomas following ICD implantation are infrequent and are not associated with significant increase in mortality. Elderly, congestive heart failure, renal failure and patients with coagulopathy are at higher risk of developing these pocket hematomas. Hematoma formation following cardiac device implantation prolongs the hospital stay significantly and is associated with increased utilization costs.